A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis
Recurrence of BV following standard treatment is unacceptably high. Posttreatment recurrence is distressing for women, and it imposes a considerable burden on the health care system.
Enregistré dans:
Auteurs principaux: | Erica L. Plummer, Lenka A. Vodstrcil, Michelle Doyle, Jennifer A. Danielewski, Gerald L. Murray, Glenda Fehler, Christopher K. Fairley, Dieter M. Bulach, Suzanne M. Garland, Eric P. F. Chow, Jane S. Hocking, Catriona S. Bradshaw |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d550f43c8e5d4ccbba8ce0a380d8c24a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
par: Catriona S Bradshaw, et autres
Publié: (2012) -
The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review
par: Larissa K. Ratten, et autres
Publié: (2021) -
Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda
par: Cindy M. Liu, et autres
Publié: (2015) -
Modelling the multiple anatomical site transmission of Mycoplasma genitalium among men who have sex with men in Australia
par: Xianglong Xu, et autres
Publié: (2021) -
Modern understanding of bacterial vaginosis
par: Aleksey A. Khryanin, et autres
Publié: (2021)